MetLife (NYSE: MET) director defers stock retainer share award

Rhea-AI Filing Summary

MetLife Inc. director Diana McKenzie reported an acquisition of common stock as part of non-management director compensation. She received a grant of 587 shares valued at $87.40 per share, increasing her direct holdings to 25,229 shares after the transaction. A portion of her director retainer is paid in MetLife stock, and she elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors, indicating this is a compensation-related, non–open-market transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider MCKENZIE DIANA

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	587	$87.40	$51K

Holdings After Transaction: Common Stock — 25,229 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Stock grant: 587 shares Grant price: $87.40 per share Holdings after grant: 25,229 shares

3 metrics

Stock grant 587 shares Common Stock grant to director on 2026-06-16

Grant price $87.40 per share Valuation used for director stock award

Holdings after grant 25,229 shares Director’s direct MetLife holdings following transaction

Key Terms

non-management director compensation arrangements, MetLife Deferred Compensation Plan for Non-Management Directors, Common Stock, Grant, award, or other acquisition

4 terms

non-management director compensation arrangements financial

"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock."

MetLife Deferred Compensation Plan for Non-Management Directors financial

"The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors."

Common Stock financial

"MetLife, Inc. common stock."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCKENZIE DIANA

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NEW YORK 10166

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/16/2026		A(1)		587	A	$87.4	25,229	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Remarks:

	/s/ Taylor McInerney Jansen, Attorney-in-fact	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did MET director Diana McKenzie report?

Diana McKenzie reported receiving a grant of MetLife common stock as director compensation. The award consisted of 587 shares tied to non-management director retainer fees and was deferred under the MetLife Deferred Compensation Plan for Non-Management Directors.

How many MetLife (MET) shares did Diana McKenzie acquire?

Diana McKenzie acquired 587 shares of MetLife common stock. These shares were granted as part of her non-management director retainer compensation rather than purchased on the open market, and their reported value was based on a price of $87.40 per share.

What is Diana McKenzie’s MetLife shareholding after this transaction?

After the grant, Diana McKenzie directly holds 25,229 shares of MetLife common stock. This total reflects the newly awarded 587 shares added to her prior holdings as reported in the filing, giving investors a consolidated view of her current direct ownership position.

Was the MET director stock transaction an open-market purchase?

No, the transaction was not an open-market purchase. It is classified as a grant or award acquisition linked to non-management director compensation, with shares paid as part of the retainer rather than bought by the director on the open market.

Why were Diana McKenzie’s MetLife shares deferred under a plan?

The filing states McKenzie elected to defer receipt of the shares under the MetLife Deferred Compensation Plan for Non-Management Directors. This plan allows directors to postpone receiving stock-based retainer fees, typically for tax or long-term compensation planning purposes.

What price per share was used for Diana McKenzie’s MET stock grant?

The stock grant for Diana McKenzie used a price of $87.40 per share. This figure is applied to the 587 awarded shares to determine the value of the compensation-related grant reported for her non-management director retainer fees.